The Dual Marker by Delfia test is a specialized prenatal screening method designed to evaluate the health and development of a pregnancy in the first trimester. It primarily measures two key biochemical markers in maternal blood – Free Beta-hCG (Human Chorionic Gonadotropin) and PAPP-A (Pregnancy Associated Plasma Protein-A). These markers, when analyzed together with maternal age and ultrasound findings, help in assessing the risk of chromosomal abnormalities such as Down syndrome (Trisomy 21), Trisomy 18, and other developmental conditions. The Delfia technology ensures high precision, reliability, and sensitivity in detecting even minor variations in biomarker levels. This test is non-invasive, safe for both mother and baby, and plays a vital role in early pregnancy care, guiding clinicians toward better monitoring and timely interventions.

• Reports On : With 96 Hours
• Sample Type : Blood
• Fasting : Not Required